Ruoding Tan

Understanding the Gap Between Efficacy in Randomized Controlled Trials and Effectiveness in Real-World Use of GLP-1 RA and DPP-4 Therapies in Patients With Type 2 Diabetes

Ginger Smith Carls, Edward Tuttle, Ruoding Tan et al. · Diabetes Care · 2017 · 150 citations

Real-world patterns of endocrine therapy for metastatic hormone-receptor-positive (HR+)/human epidermal growth factor receptor-2-negative (HER2−) breast cancer patients in the United States: 2002–2012

Elyse Swallow, Jie Zhang, Darren Thomason et al. · Current Medical Research and Opinion · 2014 · 67 citations

Drug-Drug Interaction Associated with Mold-Active Triazoles among Hospitalized Patients

David R. Andes, Nkechi Azie, Hongbo Yang et al. · Antimicrobial Agents and Chemotherapy · 2016 · 55 citations · Full text

Drug Safety, Drug Interactions, Mold-active Triazoles +15

Brain scan diagnosis of central nervous system involvement in systemic lupus erythematosus.

Ruoding Tan, Dafna D. Gladman, Murray B. Urowitz et al. · Annals of the Rheumatic Diseases · 1978 · 29 citations · Full text

Real-world weight change among patients treated with glucagon-like peptide-1 receptor agonist, dipeptidyl peptidase-4 inhibitor and sulfonylureas for type 2 diabetes and the influence of medication adherence

Ginger Smith Carls, Ruoding Tan, Jiankun Zhu et al. · Obesity Science & Practice · 2017 · 26 citations · Full text